Pediatric surgery international · 2026
Circumcision with a novel metallic disposable clamp (Alisklamp® Nero M): clinical outcomes from a 6000-patient pediatric series.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Çelik Mecit, Aras Necip Fazıl
Аннотация
PURPOSE: The Alisklamp® Nero M is a novel metallic disposable circumcision device allowing thermocautery-assisted excision, immediate device removal, and standardized mucosal cuff length. This study evaluated its real-world safety profile and complication rates in a large pediatric cohort.
METHODS: This retrospective study included 6000 boys aged 1 month to 12 years circumcised using the Alisklamp® Nero M between November 2020 and November 2025. Procedures were performed by a single experienced surgeon using a standardized local anesthesia technique. Postoperative follow-up was conducted through a structured smartphone-based telemedicine protocol until complete wound healing. Primary and secondary outcomes were overall complication and revision surgery rates, respectively.
RESULTS: The mean patient age was 3.14 ± 3.13 years. No patients were lost to follow-up. A total of 130 complications (2.16%) occurred, predominantly wound dehiscence (0.95%) and postoperative bleeding (0.58%). Revision surgery was required in only 10 patients (0.16%) due to persistent bleeding (n = 5) or secondary phimosis (n = 5). Remaining complications were managed conservatively, yielding complete mucocutaneous healing in all patients.
CONCLUSIONS: Circumcision with the Alisklamp® Nero M demonstrated low overall complication and exceptionally low revision surgery rates. Standardized excision, immediate device removal, and structured telemedicine follow-up support its safety, feasibility, and practicality in routine pediatric care.
METHODS: This retrospective study included 6000 boys aged 1 month to 12 years circumcised using the Alisklamp® Nero M between November 2020 and November 2025. Procedures were performed by a single experienced surgeon using a standardized local anesthesia technique. Postoperative follow-up was conducted through a structured smartphone-based telemedicine protocol until complete wound healing. Primary and secondary outcomes were overall complication and revision surgery rates, respectively.
RESULTS: The mean patient age was 3.14 ± 3.13 years. No patients were lost to follow-up. A total of 130 complications (2.16%) occurred, predominantly wound dehiscence (0.95%) and postoperative bleeding (0.58%). Revision surgery was required in only 10 patients (0.16%) due to persistent bleeding (n = 5) or secondary phimosis (n = 5). Remaining complications were managed conservatively, yielding complete mucocutaneous healing in all patients.
CONCLUSIONS: Circumcision with the Alisklamp® Nero M demonstrated low overall complication and exceptionally low revision surgery rates. Standardized excision, immediate device removal, and structured telemedicine follow-up support its safety, feasibility, and practicality in routine pediatric care.